Xenon Pharmaceuticals Inc. Balance Sheet

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Accumulated Depreciation 13.35M8.71M11.25M13.46M
Assets
Assets 54.49M87.42M63.95M67.49M46.12M147.70M189.19M572.01M754.15M964.80M798.14M
Current Assets
Cash & Equivalents 60.16M37.95M72.03M58.65M17.09M20.49M24.75M45.01M175.69M57.24M148.64M754.40M
Receivables - Net 0.44M0.21M0.32M0.20M0.44M0.81M1.82M2.77M0.99M0.87M1.47M
Receivables - Other 0.45M1.47M
Receivables 0.44M0.21M0.32M0.20M0.44M1.26M1.82M2.77M0.99M0.87M2.94M
Prepaid Assets 0.15M0.69M1.90M1.33M0.72M2.69M2.96M4.48M7.22M6.01M6.89M
Current Assets 49.87M84.94M60.87M65.67M44.82M144.87M181.78M559.02M600.30M644.96M635.26M
Non-Current Assets
Property, Plant & Equipment (Net) 1.88M2.48M1.99M1.40M1.07M1.66M3.55M4.47M6.50M9.65M10.28M
Long-Term Investments 128.68M292.79M127.50M
Long-Term Deferred Tax 0.24M0.52M0.47M0.51M0.80M9.67M
Other Non-Current Assets 2.74M1.09M0.41M0.23M7.75M7.40M7.50M
Non-Current Assets 4.62M2.48M3.08M1.81M1.30M2.83M7.40M12.99M153.85M319.84M162.88M
Liabilities
Current Liabilities
Accounts Payables 2.28M2.66M2.62M3.59M3.38M8.82M10.87M13.72M22.21M25.97M34.22M
Payables 2.28M2.66M2.62M3.59M3.38M8.82M10.87M13.72M22.21M25.97M34.22M
Accumulated Expenses 0.52M1.08M0.76M0.87M1.02M2.89M2.86M5.94M5.82M8.82M12.06M
Other Accumulated Expenses 0.27M0.08M0.06M0.13M0.04M0.20M0.07M0.12M0.34M0.71M
Short term Debt 0.70M4.65M
Current Leases 0.17M0.27M0.60M0.49M1.30M1.37M
Current Taxes 0.35M5.69M
Current Deferred Revenue 15.92M11.62M0.16M29.74M3.64M
Total Current Liabilities 18.20M14.29M2.78M3.59M4.08M43.38M14.78M14.32M22.70M27.27M35.59M
Non-Current Liabilities
Non-Current Debt 6.10M10.89M
Non-Current Deffered Revenue 11.89M0.16M0.71M
Operating Leases 0.74M3.05M7.65M9.95M9.60M7.65M
Other Non-Current Liabilities 0.20M0.13M0.07M
Total Non-Current Liabilities 14.44M2.78M3.52M
Liabilities
Total Liabilities 89.86M30.37M14.64M2.92M3.59M10.19M55.72M17.83M21.97M32.65M36.88M43.24M
Shareholder's Equity
Total Debt 6.80M15.54M
Common Equity -89.86M-78.37M72.78M61.03M63.90M35.93M91.98M171.35M550.03M721.50M927.92M754.90M
Shareholder's Equity -89.86M-78.37M72.78M61.03M63.90M35.93M91.98M171.35M550.03M721.50M927.92M754.90M
Liabilities and Shareholders Equity 54.49M87.42M63.95M67.49M46.12M147.70M189.19M572.01M754.15M964.80M798.14M
Retained Earnings -116.75M-103.73M-119.69M-142.68M-173.39M-249.66M-278.49M-357.37M-482.75M-665.14M-899.47M
Preferred Shares 102.49M7.73M7.73M7.73M
Treasury Shares 0.21M
Shares Outstanding 4.32M4.32M14.18M14.39M17.93M18.00M28.14M35.01M51.63M62.59M75.37M76.42M